Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Infants and toddlers with fungal infections will receive 10 to 14 days of treatment with an
antifungal drug. Safety and drug blood levels will be assessed